SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-026621
Filing Date
2023-05-25
Accepted
2023-05-25 16:05:24
Documents
23
Period of Report
2023-05-19
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc20053546_8k.htm   iXBRL 8-K 31467
2 EXHIBIT 3.1 brhc20053546_ex3-1.htm EX-3.1 4989
6 image00006.jpg GRAPHIC 64783
7 image00007.jpg GRAPHIC 49845
8 image00008.jpg GRAPHIC 18522
9 image00009.jpg GRAPHIC 120847
10 image00010.jpg GRAPHIC 136946
11 image00011.jpg GRAPHIC 155236
12 image00012.jpg GRAPHIC 142912
13 image00013.jpg GRAPHIC 140505
14 image00014.jpg GRAPHIC 74590
15 image00015.jpg GRAPHIC 35863
  Complete submission text file 0001140361-23-026621.txt   1476715

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cycn-20230519.xsd EX-101.SCH 3868
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycn-20230519_lab.xml EX-101.LAB 24035
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycn-20230519_pre.xml EX-101.PRE 17062
17 EXTRACTED XBRL INSTANCE DOCUMENT brhc20053546_8k_htm.xml XML 4384
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 23960422
SIC: 2834 Pharmaceutical Preparations